Effects of pre- and postnatal cysteamine exposure on renal function in the rat

The safety of cysteamine after renal transplantation and during pregnancy is an important issue, since girls with cystinosis are in better health on cysteamine therapy and thus more likely to become pregnant. In the first study, cysteamine was given to pregnant rats on days 6.5–18.5 post conception in oral doses of 0, 37.5, 75, 100, and 150 mg/kg per day. The dams were sacrificed on day 20.5, the fetal kidneys removed and prepared for histological examination. In the second study, cysteamine was given to dams on days 6.5–19.5 post conception in oral doses of 0, 37.5, 50, and 75 mg/kg per day. Dams were allowed to give birth naturally and pups were given cysteamine on days 4–21 to yield the same oral doses of cysteamine given to the dam. Renal function was evaluated on day 35. Histological examination of fetal kidneys revealed no changes even in kidneys from fetuses with growth retardation and malformations. Furthermore, there were no alterations in renal function in offspring on day 35. These findings demonstrate that cysteamine therapy does not affect renal development in the rat. Further investigations will be required to prove whether cysteamine therapy has the potential to affect renal development in the human. Received: 25 September 1998 / Revised: 17 November 1998 / Accepted: 13 December 1998     

Ambulatory urodynamic monitoring of external urethral sphincter behavior in chronic prostatitis patients

Aim: To study the behavior of external urethral sphincter in chronic prostatitis (CP) patient under natural filling.Methods: Twenty-one CP patients and 17 normal volunteers were involved in the study. Both the patients andvolunteers underwent ambulatory urodynamic monitoring (AM) and conventional medium filling cystometry (CMG).Urodec 500 was used for AM and Menuet for CMG. AM findings from CP patients were compared with those fromnormal volunteers, and the results from AM were compared with those from CMG. Results: In AM, the restingand voiding external urethral sphincter (EUS) pressures and maximum urethral closure pressures (MUCP) weresignificantly higher in CP patients [ ( 121.5 ±10.3) and (85.6±3.5) cm water, respectively ] than in normalvolunteers [ (77.6±11.4) and (10.3±1.6) cm water, respectively)]. Conclusion: The behavioral changes ofEUS in CP patients included spasm and instability of EUS, which were demonstrated using AM under natural filling;the findings were also in accord with the res     

精氨酸对烧伤创面愈合的影响

目的 探讨精氨酸对烧伤创面愈合的影响和量效关系。方法 通过大鼠深Ⅱ度烫伤模型,伤后肠道站充不同剂量精氨酸,观察烧伤创面愈合时间,测定烧伤创面愈合面积百分比,创面Ｉ型／Ⅲ型胶原比例,羟脯氨酸（ＯＨＰ）含量和真皮细胞增殖周期,结果 每天补充１００－４００ｍｇ／ｋｇ精氨酸可缩短烧伤创面愈合时间,增加烧伤创面中ＯＨＰ含量,降低烧伤创面Ｉ／Ⅲ型胶原比例,加速真皮细胞ＤＮＡ复制。比较喂不同剂量精氨酸各组,发现     

白细胞介素12对肝癌基因治疗的实验研究

目的 研究携带白细胞介素１２（ＩＬ－１２）基因逆转录病毒载体对体内肝癌生长抑制作用,探索基因治疗肝癌新途径。方法 构建携带ＩＬ－１２的逆转录病毒载体,转染逆转录病毒包装细胞系ＰＡ３１７,应用该包装细胞对实验性肝癌大鼠进行治疗,观察抗肿瘤作用,免疫功能变化。     

Effect of hyperbaric oxygen on microvascular anastomosis healing and patency in the rat

Recent evidence has shown that changes in blood viscosity and marked increases in both platelet count and fibrinogen concentration occur after exposure to hyperbaric oxygen (HBO). The purpose of the present study was to address whether repeated HBO therapy would increase either hematocrit or platelet count, and to determine if these changes would influence the patency of the microvascular anastomosis, as well as anastomotic healing. Eighty femoral arteries from 40 rats were divided into four groups (n = 10), and arterial anastomoses were performed on normal arteries in the first two groups, and on crushed arteries in the second two groups. One of the normal artery groups and one of the crushed artery groups received repeated HBO treatments for 5 days. Anastomotic patency rates, platelet count, hematocrit, and breaking strength were recorded. Among the results of this study were that: (1) there was no difference in patency rate following HBO treatment in both the normal and crushed artery groups; (2) platelet count was significantly higher following HBO treatment in the groups with the undamaged arteries; (3) breaking strength was significantly increased following HBO treatment in the groups with the crushed arteries. The authors concluded that HBO therapy may be useful in improving the healing of microvascular anastomoses in vessels that have undergone crush injury. Although HBO treatment results in an increased platelet count, this does not influence anastomotic patency.     

双歧杆菌对实验性大肠癌的预防及诱导细胞凋亡的作用

目的　探讨青春型双歧杆菌对实验性大肠癌的预防作用及其防瘤机制。方法　以裸鼠大肠癌移植瘤为动物模型,预先用双歧杆菌注射于裸鼠腹腔,观察移植瘤的生长速度,同时利用透射电镜、原位末端标记技术及免疫组化技术观察大肠癌裸鼠移植瘤的超微结构、凋亡细胞密度以及ｂｃｌ２、ｂａｘ 蛋白表达率及其阳性细胞密度。结果　双歧杆菌预防组大肠癌移植瘤的生长速度显著慢于对照组; 此外双歧杆菌预防组移植瘤组织中可见多量处于不同凋亡时期的瘤细胞,其凋亡细胞密度、ｂａｘ 蛋白表达率以及阳性细胞密度均显著高于肿瘤对照组,而ｂｃｌ２ 蛋白的表达情况则相反。结论　青春型双歧杆菌能显著预防大肠癌的发生与发展,并能诱导其细胞凋亡。     

芬太尼用于开胸术后硬膜外患者自控镇痛的研究

目的：研究不同配伍的芬太尼用于开胸术后PCEA的镇痛效果。方法：75例（ASAⅠ～Ⅱ级）择期剖胸患者随机分为三组,各25例,F组单用芬太尼;FB组用芬太尼＋布比卡因;FBM组用芬太尼＋布比卡因＋吗啡。观察用药总量,D／D比值,VAS评分,整体满意度,并发症。结果：用药总量F组显著大于FB及FBM组（P＜0．05）;D／D比值＜2、VAS＜3、整体满意度为优的病例数FB组及FBM组显著多于F组（P＜0．05）;恶心、皮肤瘙痒患者以FBM组最多（P＜0．05,P＜0．005）。结论：开胸术后患者使用IPCEA时以小剂量芬太尼合用低浓度布比卡因的给药模式为宜。     

外伤性白内障术前B超检查的临床意义

目的 探讨外伤性白内障术前采用Ｂ超检查后囊破损情况的临床意义。方法 外伤性白内障３０只眼,术前采用Ｂ超检查评估后囊情况,显微镜下白内障摘除术中直接观察后囊情况并记录。结果 １４只眼术前Ｂ超检查后囊完整,手术证实１２只眼后囊完整,２只眼后囊小破坏。１６只眼术前Ｂ超检查后囊破损,手术证实１４只眼后囊存在大小不等的破损,２只眼后囊完整。结论 外伤性白内障术前Ｂ超检查为非侵入性、无痛性检查方法,操作简便,     

半导体红外激光光凝治疗视网膜静脉阻塞

为探讨半导体红外激光对视网膜静脉阻塞（ＲＶＯ）的治疗效果,对５８例ＲＶＯ患者用Ｋｅｅｌｅｒ公司“Ｍｉｃｒｏｌａｓｅ”半导体激光器（波长８１０ｎｍ）作区域封闭或全视网膜光凝（ＰＲＰ）。结果：１７例中央视网膜静脉阻塞（ＣＲＶＯ）患者,治疗前后平均视力分别为０．１７５及０．４０;７例半球阻塞（Ｓｅｍｉ－ＣＲＶＯ）患者治疗前后平均视力为０．１１６及０．４０;３４例视网膜分枝静脉阻塞（ＢＲＶＯ）患者则分别为０．１９及０．４６５。经ｔ检验,差别均有显著性。结论：激光光凝治疗是ＲＶＯ重建供氧平衡的重要手段,疗效肯定。半导体红外激光有比氩激光更易穿透浑浊介质和更少影响视网膜神经纤维层和黄斑功能等优点。早期进行区域封闭或全视网膜光凝,有利于保存有用视力。